Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Editorial

Phosphorus in kidney disease: Culprit or bystander?

Malvinder S. Parmar, MB, MS, FRCPC, FASN
Cleveland Clinic Journal of Medicine August 2018, 85 (8) 639-642; DOI: https://doi.org/10.3949/ccjm.85a.18013
Malvinder S. Parmar
Professor of Medicine, Division of Clinical Sciences, Northern Ontario School of Medicine, Sudbury and Thunder Bay, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    A stepwise approach to the management of hyperphosphatemia and selection of phosphorus binder.

Tables

  • Figures
    • View popup
    TABLE 1

    Phosphorus binders

    Calcium-based
    Calcium carbonate
    Calcium acetate
    Noncalcium-based
    Metal-based
     Aluminum hydroxide (only for short-term use)
     Lanthanum carbonate
     Iron (sucroferric oxyhydroxide, ferric citrate)
    Resin-based
     Sevelamer (sevelamer hydrochloride, sevelamer carbonate)
    Others
     Magnesium hydroxide, magnesium carbonate (risk of hypermagnesemia)
     Chitosan (minimal effect)
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 85 (8)
Cleveland Clinic Journal of Medicine
Vol. 85, Issue 8
1 Aug 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Phosphorus in kidney disease: Culprit or bystander?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Phosphorus in kidney disease: Culprit or bystander?
Malvinder S. Parmar
Cleveland Clinic Journal of Medicine Aug 2018, 85 (8) 639-642; DOI: 10.3949/ccjm.85a.18013

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Phosphorus in kidney disease: Culprit or bystander?
Malvinder S. Parmar
Cleveland Clinic Journal of Medicine Aug 2018, 85 (8) 639-642; DOI: 10.3949/ccjm.85a.18013
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • PHOSPHORUS OR PHOSPHATE?
    • THE PROBLEM
    • STRATEGIES TO CONTROL HYPERPHOSPHATEMIA
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • Calcific uremic arteriolopathy
  • Phosphorus binders: The new and the old, and how to choose
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Nitrogen: The unsung hero of vascular physiology
  • The beat goes on: Highlights from the new American and European A-fib guidelines
  • Subclinical hypothyroidism: What’s in a name?
Show more Editorial

Similar Articles

Subjects

  • Drug Therapy
  • Endocrinology
  • Nephrology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire